BMP2 Induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK

Frontiers in Bioscience

Volumn 17, Issue 7, 2011, Pages 2541-2549

  Liu, Jun ^a   Ben, Qi Wen ^b   Yao, Wei Yan ^a   Zhang, Jian Jun ^c   Chen, Da Fan ^a   He, Xiang Yi ^a   Li, Lei ^a   Yuan, Yao Zong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

BMP2; EMT; ERK; MMP2; ROS

Indexed keywords

EID: 84860295781     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4069     Document Type: Article

References (52)

1. S. RaimondiP. MaisonneuveA.B. Lowenfels: Epidemiology of pancreatic cancer: an overview, Nat Rev Gastroentero. Hepatol 6, 699-708 (2009)
2. F.A. Real, 'Catastrophic hypothesis' for pancreas cancer progression. Gastroenterology 124, 1958-1964 (2003)
3. J.P. DuffyG. EiblH.A. Reber: Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2, 12 (2003)
4. J.E. NiederhuberM.F. BrennanH.R. Menck: The national cancer database report on pancreatic cancer, Cancer 76 (1995) 1671-1677.
5. K.J. Gordon, K.C. Kirkbride, T. How: Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad-1 dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 30, 238-248 (2009)
6. J.P.S. Jean Paul Thiery: Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142 (2006)
7. A. Reddi: Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8(1), 811-20, (1997)
8. J. Wozney: Overview of bone morphogenetic proteins. Spine 27, S2-S8 (2002)
9. H.I. Chen, D.M. Panchision: Concise review: bone morphogentic protein pleiotropism in neural stem cells and their derivatives-alternative pathways. Stem Cells 25, 63-68 (2007) (Pubitemid 46052975)
10. B.L.M. Hogan: Bone morphogenetic proteins: multifunctional regulators of verterbrate development. Gene Dev 10 (13), 1580-1594.
11. S. Virtanen, E. Alarmo, S. Sandstrom: Bone morphogenetic protein-4 and -5 in pancreatic cancer-Novel bidirectional players. Exp Cell Res 317(15), 2136-2146 (2011)
12. P. GhanehA. KaweshaJ.D. Evans: Molecular prognotic markers in pancreatic cancer. J Hepatobiliary Pancreat Surg 9(1), 1-11 (2002) (Pubitemid 34477366)
13. H. KuniyasuL.M. EllisD.B. Evans: Relative expression of E-cadherin and type IV collegenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 5, 35-33 (1999)
14. H. NakamuraS. HoritaN. Semaru: Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma. Oncol Rep 9, 751-755 (2002)
15. H. YammamotoF. ItahS. Iku: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 19, 1118-1127 (2001) (Pubitemid 32176289)
16. B.B. Koenig, J.S. Cook, D.H. Wolsing: Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14, 5961-5974 (1994) (Pubitemid 24264425)
17. C.H. HeldinK. MiyazonoP. ten Dijke: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471 (1997) (Pubitemid 28013118)
18. M.J. Duffy: Proteases as prognostic markers in cancer. Clin Cancer Res 2, 613-618 (1996) (Pubitemid 26133464)
19. V. Ellenrieder, B. Alber, U. Lacher: Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer 85, 14-20. (2000)
20. Hamada S, Satoh K, Hirota M, Kimura K, Kanno A, Masamune A, Shimosegawa T: Bone morphogenetic protein 4 induces epithelialmesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol, 213, 768-774 (2007) (Pubitemid 350058270)
21. M.G. Binker, A.A. Binker-Cosen, H.Y. Gaisano: TGFbeta1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-kB/IL-6/MMP2. Biochem Biophys Res Commun 405, 140-145 (2011)
22. E.C. Vaquero, M. Edderkaoui, S.J. Pandol: Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279, 34643-34654 (2004) (Pubitemid 39318094)
23. A. Acharya, I. Das, D. Chandhok: Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev 3, 23-34 (2010)
24. M.G. Binker, A.A. Binker-Cosen, D. Richards: EGF promotes invasion by PANC-1 cells through Rac1/ROSdependent secretion and activation of MMP-2. Biochem Biophys Res Commun 379, 445-450 (2009)
25. K. Kim, Y.S. Cho, J. Park: Pro-MMP-2 activation by the PPAR agonist, ciglitazone, induces cell invasion through the generation of ROS and the acetivation of ERK. FEBS Letters 581, 3303-3310 (2007) (Pubitemid 46977368)
26. L. Kuo, H. Chang, T. Leu: Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 207, 729-734 (2006) (Pubitemid 43668237)
27. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69(1), 9-16 (1996) (Pubitemid 26083264)
28. M.L. Teoh, W.Q. Sun, B.J. Smith: Modulation of reactive oxygen species in pancreatic cancer. Clin Cancer Res 13(24), 7441-7450 (2007)
29. B.-C.A. Binker MG, Richards D, Oliver B, Cosen-Binker LI: EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2. Biochem Biophys Res Commun 379, 445-450 (2009)
30. H. Deng, R. Makizumi, T.S. Ravikumar: Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp Cell Res 313, 1033-1044 (2007) (Pubitemid 46273448)
31. J.H. Clement, M. Raida, J. Sanger: Bone morphogenetic protein-2 induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Onco. 27, 401-407 (2005)
32. C.H. Yang, A. Murti, S.R. Pfeffer: Interferon alpha/beta promotes cell survival by activatin nuclear factor kappa B trhough phosphatidylinositol 3-kinase and Akt. J Biol Chem 276, 43597-43603 (2001)
33. J.P. Thiery, H. Acloque, R.Y. Huang: Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890 (2009)
34. L.A. Borthwick, S.M. Parker, K.A. Brougham: Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 64, 770-777 (2009)
35. N. Ahmed, S. Maines-Bandiera, M.A. Quinn: Molecular pathways regulating EGF-induced epitheliomesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290, C1532-1542 (2006) (Pubitemid 43830793)
36. J. YangC. DaiY. Liu: A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 16, 68-78 (2005) (Pubitemid 43073158)
37. L.A. Borthwick, A. Gardner, A. De Soyza: Transforming Growth Factor-beta1 (TGF-beta1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor alpha (TNFalpha) via Crosstalk Between the SMAD and NF-kappaB Pathways, Cancer Microenviron 4(2), 377-92 (2011).
38. E.L. Molloy, A. Adams, J.B. Moore: BMP4 induces an epithelial-mesenchymal transition-like response in adult airway epithelial cells. Growth Factors 26, 12-22 (2008) (Pubitemid 351448010)
39. M. Zeisberg, J. Hanai, H. Sugimoto: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-968 (2003) (Pubitemid 36889942)
40. C. Huang, G. Yang, T. Jiang: Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human panceatic cancer cells in vitro. J Exp Clin Cancer Res 29, 51-58 (2010)
41. C. Min, S.F. Eddy, D.H. Sherr: NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104, 733-744 (2008) (Pubitemid 351830825)
42. J.L. Bos: ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689 (1989) (Pubitemid 19213607)
43. J. Vachtenheim, I. Horakova, H. Novotna: Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin Cancer Res 1, 359-365 (1995)
44. D.S. Goodsell: The molecular perspective: The ras oncogene. Stem Cells 17, 235-236 (1999) (Pubitemid 29350216)
45. H. Watanabe-Takano, K. Takano, E. Keduka: M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation. Exp Cell Res 316, 477-490 (2010)
46. J. AbeB.C. Berk: Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 27421003-21010 (1999)
47. J.F.R. Yue, Mulder KM: Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18, 2033-2037 (1999) (Pubitemid 29150091)
48. J.P. ThieryJ.P. Sleeman: Complex networks orchestrate epithelial-mesenchymal transitions, Nat Rev Mol Cell Biol 7, 131-142 (2006) (Pubitemid 43278296)
49. J. HeubergerW: Birchmeier, Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling, Cold Spring Harb Perspect Biol 2(2), a002915 (2010).
50. L.Y.M. Jingnan, Xiaobo Zhang, Won-Seok Jo, Daniel C. Chung: Oncogenic K-ras Stimulates Wnt Signaling in Colon Cancer Through Inhibition of GSK-3β. Gastroenterology 128, 1907-1918 (2005) (Pubitemid 40824702)
51. S.J. Grille, A. Bellacosa, J. Upson: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63, 2172-2178 (2003) (Pubitemid 36538623)
52. A. Barrallo-GimenoM.A. Nieto: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151-3161 (2005) (Pubitemid 41167144)